Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.

Suppr

超能文献

作者信息

Kostapanos Michael S, Athyros Vasilios G, Karagiannis Asterios, Mikhailidis Dimitri P

出版信息

Dig Dis Sci. 2012 Apr;57(4):1109. doi: 10.1007/s10620-012-2066-y. Epub 2012 Feb 7.

DOI:10.1007/s10620-012-2066-y

PMID:22311368

Abstract

摘要

相似文献

Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.

Dig Dis Sci. 2012 Apr;57(4):1109. doi: 10.1007/s10620-012-2066-y. Epub 2012 Feb 7.

Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.非酒精性脂肪肝疾病与冠状动脉疾病的关联机制。

Dig Dis Sci. 2011 Dec;56(12):3439-49. doi: 10.1007/s10620-011-1767-y. Epub 2011 Jun 8.

The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.脂质代谢在酒精性和非酒精性肝脂肪变性发病机制中的作用。

Semin Liver Dis. 2010 Nov;30(4):378-90. doi: 10.1055/s-0030-1267538. Epub 2010 Oct 19.

Abnormalities of lipid metabolism in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的脂质代谢异常

Semin Liver Dis. 2008 Nov;28(4):351-9. doi: 10.1055/s-0028-1091979. Epub 2008 Oct 27.

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease.疾病机制：非酒精性脂肪性肝病的发病机制

Nat Clin Pract Gastroenterol Hepatol. 2005 Jan;2(1):46-53. doi: 10.1038/ncpgasthep0084.

Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.肥胖中脂质和葡萄糖代谢异常：对非酒精性脂肪性肝病的影响。

Gastroenterology. 2007 May;132(6):2191-207. doi: 10.1053/j.gastro.2007.03.055.

[Autophagy and nonalcoholic fatty liver disease].[自噬与非酒精性脂肪性肝病]

Zhonghua Gan Zang Bing Za Zhi. 2016 Aug 20;24(8):632-635. doi: 10.3760/cma.j.issn.1007-3418.2016.08.016.

Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease.硫酸化氧甾醇作为治疗非酒精性脂肪性肝病的候选药物。

Metabolism. 2012 Jun;61(6):755-8. doi: 10.1016/j.metabol.2012.01.020. Epub 2012 Mar 3.

Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.脂质代谢与肝脏炎症。一、肝脏脂肪酸摄取：在脂肪变性中的可能作用。

Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G194-8. doi: 10.1152/ajpgi.00413.2005.

Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.脂质诱导的氧化应激在喂食致动脉粥样化饮食的小鼠中引发脂肪性肝炎。

Hepatology. 2007 Nov;46(5):1392-403. doi: 10.1002/hep.21874.

引用本文的文献

Lipid overload meets S-palmitoylation: a metabolic signalling nexus driving cardiovascular and heart disease.脂质过载与S-棕榈酰化相遇：驱动心血管疾病和心脏病的代谢信号枢纽。

Cell Commun Signal. 2025 Sep 2;23(1):392. doi: 10.1186/s12964-025-02398-3.

Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.非酒精性脂肪性肝病组织学谱中的心血管风险及临床表现：最新进展

World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.

Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis.血清γ-谷氨酰转移酶和丙氨酸转氨酶浓度可预测非酒精性脂肪性肝炎患者的内皮功能障碍。

Ups J Med Sci. 2013 Nov;118(4):228-34. doi: 10.3109/03009734.2013.814734. Epub 2013 Jul 8.

Evaluation of relationship between grading of fatty liver and severity of atherosclerotic finding.脂肪肝分级与动脉粥样硬化表现严重程度之间关系的评估。

Int J Clin Exp Med. 2012;5(3):251-6. Epub 2012 Jun 15.

本文引用的文献

Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.非酒精性脂肪肝疾病与冠状动脉疾病的关联机制。

Dig Dis Sci. 2011 Dec;56(12):3439-49. doi: 10.1007/s10620-011-1767-y. Epub 2011 Jun 8.

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.在希腊阿托伐他汀和冠心病评估（GREACE）研究中，对于有冠心病和肝功能异常的患者，长期他汀类药物治疗对心血管事件的安全性和有效性：一项事后分析。

Lancet. 2010 Dec 4;376(9756):1916-22. doi: 10.1016/S0140-6736(10)61272-X. Epub 2010 Nov 23.

Effect of nonesterified fatty acids on the stability of prostacyclin activity.非酯化脂肪酸对前列环素活性稳定性的影响。

Metabolism. 1983 Jul;32(7):717-21. doi: 10.1016/0026-0495(83)90130-0.

Simulating the diabetic environment modifies in vitro prostacyclin synthesis.模拟糖尿病环境会改变体外前列环素的合成。

Diabetes. 1983 Mar;32(3):217-21. doi: 10.2337/diab.32.3.217.

The effect of non-esterified fatty acids on vascular ADP-degrading enzyme activity.

Diabetes Res Clin Pract. 1987 Jan-Feb;3(1):9-19. doi: 10.1016/s0168-8227(87)80003-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验